Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123962
Published online Nov 15, 2026. doi: 10.4251/wjgo.123962
Published online Nov 15, 2026. doi: 10.4251/wjgo.123962
Figure 3 Subgroup analysis forest map of hepatocellular carcinoma in a high risk population of hepatitis-B-virus-associated hepato cellular carcinoma.
HCC: Hepatocellular carcinoma; NAs: Nucleos(t)ide analogs; IFN: Interferon; HR: Hazard ratio; CI: Confidence interval.
- Citation: Hao M, Liu CR, Zhang M, Zhou XQ, Jiang ZC, Gao XH, Zhang X, Wang WJ, Wang YK, Jia XL, Li YP, Dang SS. Interferon therapy reduces incidence of hepatocellular carcinoma in patients with high risk of hepatitis B virus-related hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(11): 123962
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123962.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123962